Home Cart Sign in  
Chemical Structure| 138-14-7 Chemical Structure| 138-14-7

Structure of Deferoxamine Mesylate
CAS No.: 138-14-7

Chemical Structure| 138-14-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Deferoxamine mesylate as a chelating agent used to remove excess iron from the body, treat acute iron poisoning, especially in small children, used to treat hemochromatosis, that can be either genetic or acquired. It has been previously reported to induce hypoxia and hypoxia-inducible factor-1α (HIF-1α) expression.

Synonyms: Desferrioxamine B mesylate; DFOM; DFX

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Deferoxamine Mesylate

CAS No. :138-14-7
Formula : C26H52N6O11S
M.W : 656.79
SMILES Code : O=C(N(CCCCCN)O)CCC(NCCCCCN(O)C(CCC(NCCCCCN(O)C(C)=O)=O)=O)=O.CS(=O)(O)=O
Synonyms :
Desferrioxamine B mesylate; DFOM; DFX
MDL No. :MFCD00058605
InChI Key :IDDIJAWJANBQLJ-UHFFFAOYSA-N
Pubchem ID :62881

Safety of Deferoxamine Mesylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Deferoxamine Mesylate

epigenetics
GPCR
PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HepG2 cells 100 μM 48 hours To evaluate the effect of HIF1α activation on Cyp1a1 and Cyp1a2 expression. Results showed that DFO treatment increased the expression of HIF1α target genes while decreasing the expression of Cyp1a1 and Cyp1a2. PMC10235873

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00004982 Iron Overload ... More >> Thalassemia Less << Phase 1 Completed - United States, New York ... More >> Cornell University Medical College New York, New York, United States, 10021 Less <<
NCT00447694 Beta-thalassemia ... More >> Iron Overload Less << Phase 2 Completed - United States, California ... More >> Childrens Hospital of Los Angeles Los Angeles, California, United States, 90027 Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 Less <<
NCT00110266 Myelodysplastic Syndrome ... More >> Iron Overload Less << Phase 2 Completed - -
NCT00001203 - Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02065492 Thalassemia Phase 2 Phase 3 Completed - Pakistan ... More >> Aga Khan University Hospital Karachi, Sindh, Pakistan, 74800 Less <<
NCT00293098 - - - United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00000595 Anemia (Iron-Loading) ... More >> Beta-Thalassemia Hematologic Diseases Hemoglobinopathies Thalassemia Iron Overload Hemochromatosis Less << Phase 2 Completed - -
NCT01905774 - Completed - Israel ... More >> Ha'Emek Medical Center Afula, Israel, 18101 Less <<
NCT00749515 Transfusion-dependent Hemachro... More >>matosis Thalassemia Major Sickle Cell Disease Less << Phase 4 Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 Less <<
NCT01996683 Beta-thalassemia ... More >> Serum Ferritin Iron Chelation Therapy Less << Not Applicable Unknown November 2015 Egypt ... More >> Pediatric Hematology clinic, Ain Shams University Not yet recruiting Cairo, Egypt Principal Investigator: Mohsen S Elalfy, professor          Sub-Investigator: Amira A Adly, Assist. prof.          Sub-Investigator: Yasmine I Elhenawy, lecturer Less <<
NCT01956799 - Active, not recruiting December 2018 Italy ... More >> Ematologia, AO SS. Antonio e Biagio Alessandria, AL, Italy, 15121 Clinica di Ematologia, AOU Ospedale di Torrette Ancona, AN, Italy, 60020 Ematologia con trapianto, AOU Policlinico di Bari Bari, BA, Italy, 70124 Istituto di Ematologia e Oncologia Medica, Policlinico S.Orsola Bologna, BO, Italy, 40138 Ematologia, Spedali Civili Brescia, BS, Italy, 25123 Struttura complessa di Ematologia, ASO S.Croce e Carle Cuneo, CN, Italy, 12100 Cattedra di Ematologia Policlino Careggi Firenze, FI, Italy, 50134 Clinica Ematologica, Università di Genova Genova, GE, Italy, 16132 U.O. Clinica Medicina Interna, IRCCS San Martino IST Genova, GE, Italy, 16132 UO Ematologia e CTMO, Ospedale Civile G. da Saliceto Piacenza, PC, Italy, 29121 Ematologia, Università di Padova Padova, PD, Italy, 35128 Struttura Cattedra di Ematologia e CTMO, AOU di Parma Parma, PR, Italy, 43100 Ematologia e Centro Trapianti, Centro di Riferimento Oncologico della Basilicata Rionero in Vulture, PZ, Italy, 85028 Medicina Interna II Divisione di Ematologia, Ospedale S. Luigi Gonzaga Orbassano, TO, Italy, 10043 Ematologia 2, AOU Città della Salute e della Scienza Torino, TO, Italy, 10126 S.C.D.U. Ematologia e Terapie cellulari, Ospedale Mauriziano Torino, TO, Italy, 10128 UOC Ematologia, Ospedale S.Eugenio Roma, Italy, 00144 Policlinico A.Gemelli Roma, Italy, 00168 UOC Ematologia, AO S. Giovanni Addolorata Roma, Italy, 00184 Ematologia, AO S. Andrea Roma, Italy, 00189 Less <<
NCT02875262 Intracranial Aneurysm ... More >> Subarachnoid Hemorrhage Less << Phase 1 Phase 2 Not yet recruiting June 1, 2018 Netherlands ... More >> Radboudumc Not yet recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Contact: Jeroen Boogaarts, M.D., Ph.D.    0031243615085    jeroen.boogaarts@radboudumc.nl    Contact: Joost de Vries, M.D., Ph.D.    0031243615085    joost.devries@radboudumc.nl    University Medical Center Groningen Not yet recruiting Groningen, Netherlands, 9713 GZ Contact: Marc van Dijk, M.D., Ph.,D.    00310503616161    j.m.c.van.dijk@umcg.nl    Contact: Rob Groen, M.D., Ph.,D.    00310503616161    r.j.m.groen@umcg.nl Less <<
NCT00105495 Thalassemia Major ... More >> Hemosiderosis Less << Phase 4 Completed - Greece ... More >> 1st Department of Pediatrics, Athens University, Aghia Sophia Children's Hospital Athens, Greece, 11527 Aghia Sophia Children's Hospital Athens, Greece, 11527 Italy Ospedale Regionale Microcitemie, Dipartimento di Scienze Cagliari, Sardegna, Italy, 09100 Dipartimento di Scienze e Dell' Adolescenza, University of Turin Turin, Italy, 10126 Less <<
NCT03137966 Diabetic Foot Ulcer Phase 2 Not yet recruiting December 31, 2022 -
NCT00658411 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Less << Not Applicable Terminated(Closed due to slow ... More >>patient accrual) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00658411 - Terminated(Closed due to slow ... More >>patient accrual) Less << - -
NCT00738413 Thalassemia Phase 1 Phase 2 Unknown December 2009 United States, New York ... More >> Weill Cornell Medical Center Recruiting New York, New York, United States, 10021 Contact: Robert W Grady, Ph.D.    212-746-3422    rwgrady@med.cornell.edu    Contact: Kristen Muirhead, BS    212-746-3264    krm2066@med.cornell.edu    Principal Investigator: Robert W Grady, Ph.D.          Sub-Investigator: Patricia J Giardina, M.D. Less <<
NCT01511848 Beta-thalassemia Major ... More >> Sickle Cell Disease Iron Hemosiderosis Less << Phase 2 Phase 3 Unknown February 2013 Egypt ... More >> Pediatric Hematology clinic, Ain Shams University Not yet recruiting Cairo, Egypt Less <<
NCT01752153 Immune Abnormalities Phase 1 Completed - Iran, Islamic Republic of ... More >> Department of Immunology, School of Medicine, Shiraz University of Medical Sciences Shiraz, Fars, Iran, Islamic Republic of Less <<
NCT00999349 Beta-thalassemia Major ... More >> Iron Overload Less << Phase 2 Phase 3 Unknown - Iran, Islamic Republic of ... More >> Isfahan University of Medical Sciences Isfahan, Iran, Islamic Republic of, 81744-176 Less <<
NCT02216513 Subarachnoid Hemorrhage Early Phase 1 Terminated(Principle Investiga... More >>tor is moving to another institution and plans to restart this proctocol in the new location.) Less << - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT02367248 Intracerebral Hemorrhage Phase 1 Phase 2 Unknown December 2016 China ... More >> Department of Neurology,Beijing Shijitan Hospital,Capital Medical University Recruiting Beijing, China, 100038 Contact: Maolin He, MD    0086-010-63926550    maolinh@sina.com Less <<
NCT01365104 Stroke Proble... More >>m of Aging Less << Early Phase 1 Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT01662895 Intracerebral Hemorrhage Phase 2 Suspended(By DSMB due to incre... More >>ased incidence of ARDS. See modified protocol [NCT02175225) Less << December 2018 -
NCT00598572 Intracerebral Hemorrhage Phase 1 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00901199 Thalassemia I... More >>ron Overload Less << Phase 4 Completed - United States, California ... More >> CHRCO Oakland, California, United States, 94609 Less <<
NCT00349453 Hemochromatosis Phase 2 Completed - Switzerland ... More >> Cantonal Hospital, Children's Clinic Aarau, Aargau, Switzerland, 5001 Cantonal Hospital Aarau, Aargau, Switzerland, 5001 Cantonal Hospital Graubünden Chur, Graubünden, Switzerland, 7000 Private practice Arzo, Ticino, Switzerland, 6864 Private practice Lugano, Ticino, Switzerland, 6900 Regional Hospital Lugano, Ticino, Switzerland, 6900 Private practice Riva San Vitale, Ticino, Switzerland, 6826 Private children's practice Brig, Wallis, Switzerland, 3900 Private practice Oerlikon, Zurich, Switzerland, 8050 Private children's practice Bern, Switzerland, 3014 Children's Hospital of Eastern Switzerland St. Gallen, Switzerland, 9006 University Children's Hospital Zurich, Switzerland, 8032 University Hospital Zurich, Switzerland, 8091 Less <<
NCT00350662 Hemochromatosis Phase 3 Completed - Egypt ... More >> Pediatric Hospital, Cairo University Cairo, Egypt Turkey EGE University Medical School Bornova, Izmir, Izmir, Turkey, 35100 Less <<
NCT01369719 Thalassemia I... More >>ron Overload Transfusion Related Complications Less << Not Applicable Completed - Iran, Islamic Republic of ... More >> Hormozgan University of Medical Sciences (HUMS) Bandar abbas, Hormozgan, Iran, Islamic Republic of, 79145-3388 Less <<
NCT02175225 Intracerebral Hemorrhage Phase 2 Active, not recruiting December 31, 2018 -
NCT03085771 Diabetes Mellitus, Type 1 Phase 2 Recruiting December 12, 2022 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Sergiu Catrina, ass prof MD    +46-8-51770000    sergiu-bogdan.Catrina@ki.se    Contact: Neda Ekberg, PhD, MD    +46-(0)8 51775449    Neda.Ekberg@ki.se Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.52mL

0.30mL

0.15mL

7.61mL

1.52mL

0.76mL

15.23mL

3.05mL

1.52mL

References

 

Historical Records

Categories